Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
[Sn-117m]-DOTA-Annexin V by Serene for Atherosclerosis: Likelihood of Approval
[Sn-117m]-DOTA-Annexin V is under clinical development by Serene and currently in Phase II for Atherosclerosis. According to GlobalData, Phase II...